ALTERED DISTRIBUTION OF DEBRISOQUINE OXIDATION PHENOTYPES IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS

被引：48
作者：
BAER, AN
MCALLISTER, CB
WILKINSON, GR
WOOSLEY, RL
PINCUS, T
机构：
[1] VANDERBILT UNIV, DEPT MED, NASHVILLE, TN 37240 USA
[2] VANDERBILT UNIV, DEPT PHARMACOL, NASHVILLE, TN 37240 USA
[3] VET ADM MED CTR, NASHVILLE, TN 37203 USA
来源：
ARTHRITIS AND RHEUMATISM | 1986年 / 29卷 / 07期
关键词：
D O I：
10.1002/art.1780290705
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：843 / 850
页数：8
相关论文
共 43 条
[1]   IMPAIRMENT OF HEPATIC DRUG OXIDATION BY PROPOXYPHENE [J].
ABERNETHY, DR ;
GREENBLATT, DJ ;
STEEL, K ;
SHADER, RI .
ANNALS OF INTERNAL MEDICINE, 1982, 97 (02) :223-224
[2]   METABOLIC OXIDATION PHENOTYPES AS MARKERS FOR SUSCEPTIBILITY TO LUNG-CANCER [J].
AYESH, R ;
IDLE, JR ;
RITCHIE, JC ;
CROTHERS, MJ ;
HETZEL, MR .
NATURE, 1984, 312 (5990) :169-170
[3]   FURTHER EVIDENCE FOR THE LACK OF ASSOCIATION BETWEEN ACETYLATOR PHENOTYPE AND SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
BAER, AN ;
WOOSLEY, RL ;
PINCUS, T .
ARTHRITIS AND RHEUMATISM, 1986, 29 (04) :508-514
[4]  
BOOBIS AR, 1983, MOL PHARMACOL, V23, P474
[5]  
BRANCH RA, 1985, CLIN RES, V33, pA527
[6]  
CARR K, 1978, BRIT J CLIN PHARMACO, V6, P421, DOI 10.1111/j.1365-2125.1978.tb04606.x
[7]  
CHENG KC, 1984, DRUG METAB DISPOS, V12, P222
[8]  
CONNEY AH, 1982, CANCER RES, V42, P4875
[9]   MULTIPLE TESTING OF HYPOTHESES IN COMPARING 2 GROUPS [J].
CUPPLES, LA ;
HEEREN, T ;
SCHATZKIN, A ;
COLTON, T .
ANNALS OF INTERNAL MEDICINE, 1984, 100 (01) :122-129
[10]   VARIANTS OF HUMAN MICROSOMAL-ENZYMES [J].
DAVIES, DS ;
BOOBIS, AR .
BIOCHEMICAL SOCIETY TRANSACTIONS, 1983, 11 (04) :459-460
12345